Ostrum Asset Management’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$599K Buy
5,280
+956
+22% +$94.8K 0.03% 294
2026
Q1
$407K Sell
4,324
-4,450
-51% -$444K 0.02% 352
2025
Q4
$867K Sell
8,774
-2,907
-25% -$281K 0.04% 297
2025
Q3
$991K Sell
11,681
-361
-3% -$28.5K 0.04% 315
2025
Q2
$820K Sell
12,042
-344
-3% -$21.8K 0.04% 339
2025
Q1
$750K Sell
12,386
-9,219
-43% -$643K 0.04% 352
2024
Q4
$1.49M Sell
21,605
-55,773
-72% -$3.97M 0.13% 247
2024
Q3
$5.11M Sell
77,378
-21,273
-22% -$1.36M 0.42% 48
2024
Q2
$5.98M Buy
98,651
+3,522
+4% +$199K 0.52% 31
2024
Q1
$5.42M Hold
95,129
0.43% 42
2023
Q4
$5.97M Buy
95,129
+7,659
+9% +$433K 0.52% 32
2023
Q3
$5.05M Sell
87,470
-1,163
-1% -$73.3K 0.47% 40
2023
Q2
$5.52M Sell
88,633
-613
-0.7% -$41K 0.46% 44
2023
Q1
$6.45M Buy
+89,246
New +$6.98M 0.56% 25

Other funds holding INCY

Ostrum Asset Management's INCY Position: Q2 2026 in Review

Ostrum Asset Management increased its Incyte (INCY) stake by 22% in Q2 2026, buying an estimated $94.8K and bringing the position to 5,280 shares worth $599K. The position accounts for 0.03% of the portfolio, ranked #294.

Ostrum Asset Management first reported a position in INCY in Q1 2023 and has held it in 14 quarters since. The position peaked at $6.45M in Q1 2023. 858 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

  • Ostrum Asset Management held 5,280 shares of Incyte worth $599K as of Q2 2026.
  • Ostrum Asset Management bought 956 Incyte shares in Q2 2026, an estimated $94.8K.
  • Incyte made up 0.03% of Ostrum Asset Management's portfolio in Q2 2026, its #294 holding.
  • Ostrum Asset Management first reported a position in Incyte in Q1 2023 and has held it in 14 quarters since.
  • Ostrum Asset Management's Incyte position peaked at $6.45M in Q1 2023.
  • 858 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on Ostrum Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.